Fosmidomycin sodium

ID: ALA2164257

Chembl Id: CHEMBL2164257

Cas Number: 66508-37-0

PubChem CID: 5141362

Product Number: F302004

Max Phase: Preclinical

Molecular Formula: C4H9NNaO5P

Molecular Weight: 183.10

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: Fosmidomycin Sodium | Fosmidomycin Sodium Salt|Fosmidomycin Sodium|66508-37-0|(3-(Formylhydroxyamino)propyl)phosphonic acid monosodium salt|IYI1EW66CX|Phosphonic acid, (3-(formylhydroxyamino)propyl)-, monosodium salt|66508-37-0 (sodium)|FR 31564|FR-31564|Antibiotic FR 31564|UNII-IYI1EW66CX|SCHEMBL4432387|CHEMBL2164257|DTXSID10216711|FOSMIDOMYCIN SODIUM [JAN]|CHEBI:201600|FOSMIDOMYCIN MONOSODIUM SALT|AKOS030254266|FOSMIDOMYCIN MONOSODIUM SALT [MI]|HY-112853|CS-0067087|FT-0613838|Q27280957|sodium;Show More

Canonical SMILES:  O=CN(O)CCCP(=O)([O-])O.[Na+]

Standard InChI:  InChI=1S/C4H10NO5P.Na/c6-4-5(7)2-1-3-11(8,9)10;/h4,7H,1-3H2,(H2,8,9,10);/q;+1/p-1

Standard InChI Key:  ZZPUYRHMTGOTEU-UHFFFAOYSA-M

Associated Targets(Human)

Homo sapiens (32628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MRC5 (9203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MTARC2 Tbio Mitochondrial amidoxime reducing component 2 (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MTARC1 Tbio Mitochondrial amidoxime-reducing component 1 (51 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
dxr 1-deoxyxylulose-5-phosphate reductoisomerase (147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DXR 1-deoxy-D-xylulose 5-phosphate reductoisomerase, apicoplastic (44 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
dxr 1-deoxy-D-xylulose 5-phosphate reductoisomerase (31 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
dxr 1-deoxy-D-xylulose 5-phosphate reductoisomerase (191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 183.10Molecular Weight (Monoisotopic): 183.0297AlogP: -0.60#Rotatable Bonds: 5
Polar Surface Area: 98.07Molecular Species: ACIDHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.81CX Basic pKa: CX LogP: -2.21CX LogD: -4.60
Aromatic Rings: 0Heavy Atoms: 11QED Weighted: 0.23Np Likeness Score: 0.55

References

1. Brücher K, Illarionov B, Held J, Tschan S, Kunfermann A, Pein MK, Bacher A, Gräwert T, Maes L, Mordmüller B, Fischer M, Kurz T..  (2012)  α-Substituted β-oxa isosteres of fosmidomycin: synthesis and biological evaluation.,  55  (14): [PMID:22731758] [10.1021/jm300652f]
2. Konzuch S, Umeda T, Held J, Hähn S, Brücher K, Lienau C, Behrendt CT, Gräwert T, Bacher A, Illarionov B, Fischer M, Mordmüller B, Tanaka N, Kurz T..  (2014)  Binding modes of reverse fosmidomycin analogs toward the antimalarial target IspC.,  57  (21): [PMID:25254502] [10.1021/jm500850y]
3. Wang X, Edwards RL, Ball H, Johnson C, Haymond A, Girma M, Manikkam M, Brothers RC, McKay KT, Arnett SD, Osbourn DM, Alvarez S, Boshoff HI, Meyers MJ, Couch RD, Odom John AR, Dowd CS..  (2018)  MEPicides: α,β-Unsaturated Fosmidomycin Analogues as DXR Inhibitors against Malaria.,  61  (19): [PMID:30192536] [10.1021/acs.jmedchem.8b01026]
4. Courtens C, Risseeuw M, Caljon G, Cos P, Van Calenbergh S..  (2018)  Acyloxybenzyl and Alkoxyalkyl Prodrugs of a Fosmidomycin Surrogate as Antimalarial and Antitubercular Agents.,  (10): [PMID:30344904] [10.1021/acsmedchemlett.8b00223]
5. Courtens C, Risseeuw M, Caljon G, Cos P, Martin A, Van Calenbergh S..  (2019)  Phosphonodiamidate prodrugs of N-alkoxy analogs of a fosmidomycin surrogate as antimalarial and antitubercular agents.,  29  (9): [PMID:30857749] [10.1016/j.bmcl.2019.03.008]
6. Courtens C, Risseeuw M, Caljon G, Maes L, Cos P, Martin A, Van Calenbergh S..  (2019)  Double prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents.,  29  (10): [PMID:30879839] [10.1016/j.bmcl.2019.03.009]
7. Lienau C, Gräwert T, Alves Avelar LA, Illarionov B, Held J, Knaab TC, Lungerich B, van Geelen L, Meier D, Geissler S, Cynis H, Riederer U, Buchholz M, Kalscheuer R, Bacher A, Mordmüller B, Fischer M, Kurz T..  (2019)  Novel reverse thia-analogs of fosmidomycin: Synthesis and antiplasmodial activity.,  181  [PMID:31382119] [10.1016/j.ejmech.2019.07.058]
8. Indorf P, Kubitza C, Scheidig AJ, Kunze T, Clement B..  (2020)  Drug Metabolism by the Mitochondrial Amidoxime Reducing Component (mARC): Rapid Assay and Identification of New Substrates.,  63  (12): [PMID:31790578] [10.1021/acs.jmedchem.9b01483]
9. Kesharwani S, Sundriyal S..  (2021)  Non-hydroxamate inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): A critical review and future perspective.,  213  [PMID:33303239] [10.1016/j.ejmech.2020.113055]

Source